Search results
What's in a Name: Defining Difficult-to-Treat axSpA and PsA
Medscape· 3 days agoDespite an expanding arsenal of disease-modifying antirheumatic drugs (DMARDs), many patients with...
Innovent braves bruising cytokine space, linking fusion protein to tumor responses in small study
FierceBiotech· 3 days agoInnovent Biologics' bispecific immuno-oncology candidate IBI363 has been linked to a 100% response rate in a small cohort of Chinese lung cancer patients. IBI363 is a bispecific antibody fusion ...
7 Stocks Warren Buffett Has Sold in the Past Year (and You Should Too)
InvestorPlace· 7 days agoThe Oracle of Omaha is by far the most well-known long-term investor we have alive today, and if you...
J&J-backed Bright Peak secures $90m to advance immunoconjugate programme
Pharmaceutical Technology via Yahoo Finance· 5 days agoBright Peak Therapeutics has raised $90m in a Series C financing round as the biotech looks to make...
Expert Perspectives on Biggest Court Cases
Law.com· 3 days agoKirkland & Ellis scored a knockout win for Sun Pharmaceutical Industries Ltd. in a more than decadelong multidistrict litigation where the company was accused of conspiring to delay the launch ...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo Finance· 7 days agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
Taye Diggs’ Champions Wellness Campaign After Sister Diagnosed With Schizophrenia
Black America Web· 7 days agoTaye Diggs is shining a spotlight on schizophrenia after his younger sister Christian was diagnosed...
Experts Focus on Quality-of-Life Data in Prostate Cancer
Medscape· 6 days agoSeveral trials presented at ASCO 2024 explored strategies to improve quality of life in patients with prostate cancer.
Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee...
Morningstar· 6 days agoLawsuits have been filed alleging that a number of large corporate employers have offloaded billions of dollars in pension obligations to Athene Annuity and Life Company and/or Athene Annuity ...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 3 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....